Targeted Therapy for RET Fusion Lung Cancer: Breakthrough and Unresolved Issue - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34497761/

Molecular drugs targeting mutated or rearranged oncogene drivers have become one of the standard recognized treatments in patients with advanced and recurrent non-small cell lung cancer. RET is located in the long arm of human chromosome 10 and encodes a receptor tyrosine kinase protein, and ...